Neddylation Inhibition Boosts Radiation Response in Rhabdomyosarcoma
In a groundbreaking study published in Cell Death Discovery, researchers have unveiled a promising new avenue for treating PAX3–FOXO1 rhabdomyosarcoma, an aggressive pediatric cancer notorious...
















